Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

The application of haploidentical hematopoietic stem cell transplantation (HSCT) with mesenchymal stem cell (MSC) infusion as a treatment regimen for severe aplastic anemia (SAA) has been reported to be efficacious in single-arm trials. However, it is difficult to assess without comparing the result...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Ther Adv Hematol
Main Authors: Liu, Zenghui, Wu, Xiaoxiong, Wang, Shunqing, Xia, Linghui, Xiao, Haowen, Li, Yonghua, Li, Hongbo, Zhang, Yuping, Xu, Duorong, Nie, Danian, Lai, Yongrong, Wu, Bingyi, Lin, Dongjun, Du, Xin, Jiang, Zujun, Gao, Yang, Gu, Xuekui, Xiao, Yang
פורמט: Artigo
שפה:Inglês
יצא לאור: SAGE Publications 2020
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605036/
https://ncbi.nlm.nih.gov/pubmed/33194162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720965411
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים